Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
BCRX
$8.33
+0.73%
BCRX
· Biocryst Pharmaceuticals Inc
$8.33
+0.06 (+0.73%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$2.11B
Shares
255.54M
Volume · Sep 30
13.1M
Avg daily vol (3M)
4.19M
All earnings calls
Earnings call · FY2019 Q4
Biocryst Pharmaceuticals Inc (BCRX) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$39.73M
+1355.7% YoY
Net income
-$2.62M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 5, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 13, 2020 · complete as-filed document